KTTAClinical Trialsglobenewswire

Pasithea Therapeutics Updates Time of Presentation at the H.C. Wainwright 27th Annual Global Investment Conference

Sentiment:Negative (10)

Summary

(NASDAQ:KTTA) Pasithea Tx (Nasdaq: KTTA) to present PAS-004 clinical progress at H.C. Wainwright Global Investment Conference on Sept. 8, 2025 in NYC.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 29, 2025 by globenewswire